Screener
Indivior Pharmaceuticals, Inc. INDV Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s income tax?
- Indivior Pharmaceuticals, Inc. (INDV) reported income tax of $26M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s income tax changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s income tax increased by 136.4% year-over-year, from $11M to $26M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s income tax?
- Over 2 years (2022 to 2024), Indivior Pharmaceuticals, Inc.'s income tax has grown at a -45.0% compound annual growth rate (CAGR), from -$43M to $13M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Indivior Pharmaceuticals, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude